Home/Filings/4/A/0001209191-16-145548
4/A//SEC Filing

Spring Bank Pharmaceuticals, Inc. 4/A

Accession 0001209191-16-145548

CIK 0001566373operating

Filed

Oct 10, 8:00 PM ET

Accepted

Oct 11, 4:02 PM ET

Size

9.0 KB

Accession

0001209191-16-145548

Insider Transaction Report

Form 4/AAmended
Period: 2016-05-11
Transactions
  • Exercise of In-Money

    Common Stock

    2016-05-11$8.00/sh+9,375$75,0009,375 total(indirect: See Footnote)
  • Exercise of In-Money

    Common Stock

    2016-05-11$9.00/sh+10,416$93,74419,791 total(indirect: See Footnote)
Footnotes (5)
  • [F1]The original filing on May 12, 2016 (SEC Accession No. 0000899243-16-019806) (the "Original Form 4") erroneously over-reported the total shares held following the transaction by 10,000 shares, and mistakenly indicated that such shares were directly held by Katherine Eichler and beneficially owned by the Reporting Person. The Original Form 4 is hereby amended to reflect that 9,375 shares were held directly by Teresa Eichler as custodian for Katherine Eichler UGMA NJ, and beneficially owned by the Reporting Person, on May 12, 2016 following the reported transaction.
  • [F2]These shares are directly held by Teresa Eichler as custodian for Katherine Eichler UGMA NJ. Teresa Eichler and Katherine Eichler are immediate family members sharing a household with the Reporting Person.
  • [F3]The Original Form 4 is hereby amended to delete the line items which appeared in Table I and Table II erroneously reporting that the Reporting Person was the indirect beneficial owner of 19,791 warrants, which were exercised for 19,791 shares of common stock of the Company, held directly by Pauline Eichler. The Reporting Person is not a beneficial owner of securities held by Pauline Eichler, with whom he does not share a household, nor was he at the time of the original filing.
  • [F4]The Original Form 4 is hereby amended to delete the line items which appeared in Table I and Table II erroneously reporting that the Reporting Person was the indirect beneficial owner of 19,791 warrants, which were exercised for 19,791 shares of common stock of the Company, held directly by Emerson Eichler. The Reporting Person is not a beneficial owner of securities held by Emerson Eichler, with whom he does not share a household, nor was he at the time of the original filing.
  • [F5]The Original Form 4 is hereby amended to delete the line items which appeared in Table I and Table II erroneously reporting that the Reporting Person was the indirect beneficial owner of 19,791 warrants, which were exercised for 19,791 shares of common stock of the Company, held directly by Lindsay Eichler. The Reporting Person is not a beneficial owner of securities held by Lindsay Eichler, with whom he does not share a household, nor was he at the time of the original filing.

Issuer

Spring Bank Pharmaceuticals, Inc.

CIK 0001566373

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001566373

Filing Metadata

Form type
4/A
Filed
Oct 10, 8:00 PM ET
Accepted
Oct 11, 4:02 PM ET
Size
9.0 KB